Human Insulin Market by Product (Drug and Drug Delivery Devices) for Type 1 Diabetes, Type 2 Diabetes Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global Human Insulin market accounted for USD 27.00 billion in 2015 and is expected to reach USD 43.6 billion by 2021, growing at a CAGR of around 8.3% between 2016 and 2021

23-Aug-2016 | Number of pages: 110 | Report Code: ZMR-101 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the human insulin market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the human insulin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the human insulin market on a global level.

This report offers comprehensive coverage on global human insulin market along with, market trends, drivers, and restraints of human insulin market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the human insulin market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the human insulin market by segmenting the market based on product, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The product based market covered under this study includes drugs and drug delivery devices. The application segmentation includes insulin dependent diabetes mellitus and non-insulin dependent diabetes mellitus. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Key market players of human insulin market include Eli Lilly, GlaxoSmithCline, Biocon, Sanofi Aventis, Julphar, Novo Nordisk, SemBioSys, and Wockhardt.

This report segments the global human insulin market as follows:

Human Insulin Market: Product Segment Analysis

  • Drugs
    • Insulin Analogs and Biosimilars
    • Human Insulin Biologics
  • Drug Delivery Devices
    • Pens
    • Pen Needles
    • Syringes

Human Insulin Market: Application Segment Analysis

  • Insulin dependent diabetes mellitus (Type 1)
  • Non-Insulin dependent diabetes mellitus (Type 2)

Human Insulin Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Related Reports

Population Health Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-781 | Report Format:

Global Population Health Management Market: Overview Software and services employed by the healthcare providers, employers, and payers to improve the health of the patient in lower cost are known as population health management (PHM). The benefits associated with the identification of at-risk pa...Read More

Nerve Repair and Regeneration Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-757 | Report Format:

Global Nerve Repair and Regeneration Market: Overview Nerve repair and regeneration (NRaR) market is a mechanism which involves generation of new neurons, glial cells, myelin, synapses and axons. It is a division of neural tissue engineering. In nerve repair and regeneration, regrowth or repair ...Read More

Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials and Gastrointestinal Biomaterials) by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Jan-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-744 | Report Format:

The biomaterial market report includes inclusive view and study in Brazil. The report gives historic data of 2016 along with the forecast from 2017 to 2022 based on revenue (USD Billion). The study comprises drivers, restraints and opportunities for the biomaterial market along with the impact on ...Read More

Wound Care Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-740 | Report Format:

Global Wound Care Market: Overview A type of injury which is caused due to blow, cut, forceful impacts, and breaks the skin and tissues is termed as the wound. In the day-to-day life, we often come across some unexpected accidents which lead to minor or major wounds to our body. In medical term,...Read More

Animal Wound Care Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-694 | Report Format:

Global Animal Wound Care Market: Overview Animals are likely to have everyday small injuries such as contusions, abrasions, and lacerations which heal with treatment and may not be life threatening. But some wounds can be serious that can need sutures and even extreme care. The increasing demand...Read More

Choose License Type: